Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer

A. Drilon, G. R. Oxnard, D. S.W. Tan, H. H.F. Loong, M. Johnson, J. Gainor, C. E. McCoach, O. Gautschi, B. Besse, B. C. Cho, N. Peled, J. Weiss, Y. J. Kim, Y. Ohe, M. Nishio, K. Park, J. Patel, T. Seto, T. Sakamoto, E. RosenM. H. Shah, F. Barlesi, P. A. Cassier, L. Bazhenova, F. De Braud, E. Garralda, V. Velcheti, M. Satouchi, K. Ohashi, N. A. Pennell, K. L. Reckamp, G. K. Dy, J. Wolf, B. Solomon, G. Falchook, K. Ebata, M. Nguyen, B. Nair, E. Y. Zhu, L. Yang, X. Huang, E. Olek, S. M. Rothenberg, K. Goto, V. Subbiah*, A. Drilon

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

557 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry